Saltroad, the clinician-led speech and language therapy (SLT) provider, has raised £1.5 million and acquired Ogma, an AI documentation platform designed for SLT. The round was led by Techstart Ventures, with participation from Ascension, ScaleX and a group of prominent angel investors.
An estimated 1 in 5 children - around two million in the UK - need support with speech, language and communication, and demand far outstrips supply.
Services built for a different era can't keep pace, and families and therapists have been left to absorb the trade-offs: reports instead of therapy, rationed time, endless admin and caseloads that don’t fit.
Saltroad's premise is that none of this is inevitable. It gives families private access to NHS speech and language therapists, meaning a wider pool of specialists to choose from, therapists matched to their child's clinical needs, no waiting lists, and support that costs less than traditional private therapy.
Integrating the Ogma acquisition turns the raw material of a therapy session into structured, clinically useful notes - cutting after-hours admin and standardising record quality across the workforce.
